The Development of Therapeutic Monoclonal Antibody Products 2017: A Comprehensive Guide to CMC Activities from Clone to Clinic - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "The Development of Therapeutic Monoclonal Antibody Products" report to their offering.

"The Development of Therapeutic Monoclonal Antibodies" Second Edition goes beyond other reports by incorporating the latest technical developments and integrating strategic and regulatory considerations with these technical requirements. This report will serve as a guide to product development companies, service providers, investors, and analysts as they work their way through the complex and rapidly evolving world of therapeutic monoclonal antibodies.

As the pharmaceutical market in the United States and the rest of the world continues to expand, biopharmaceutical products have taken on increasing importance in the treatment of disease. Sales of monoclonal antibody products have grown from approximately $50 billion in 2010 to almost $90 billion in 2015, an approximately 1.8-fold increase and represent approximately 58% of biopharmaceutical sales.

As more and more exciting monoclonal antibody products for treatment of cancer, autoimmune diseases, cardiovascular disease, and others are introduced, sales from new products approved in the coming years will drive the world-wide sales of monoclonal antibody products to approximately $110 billion by 2018 and nearly $150 billion by 2021.

Key Topics Covered:

Chapter 1: The Therapeutic Monoclonal Antibody Market

Chapter 2: Overview of Chemistry, Manufacturing, and Control Activities for Monoclonal Antibody Product Development

Chapter 3: Quality by Design

Chapter 4: Analytical Development

Chapter 5: Cell Line Development and Engineering

Chapter 6: Cell Culture Development and Scale-up

Chapter 7: Purification Development

Chapter 8: Formulation Development and Stability

Chapter 9: Drug Product Manufacturing

Chapter 10: Comparability

Chapter 11: Process Validation

Chapter 12: Manufacturing Strategies

For more information about this report visit https://www.researchandmarkets.com/research/gj5hxl/the_development

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology, Biopharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology, Biopharmaceuticals